These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 20876876

  • 1. Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
    Demenais F, Mohamdi H, Chaudru V, Goldstein AM, Newton Bishop JA, Bishop DT, Kanetsky PA, Hayward NK, Gillanders E, Elder DE, Avril MF, Azizi E, van Belle P, Bergman W, Bianchi-Scarrà G, Bressac-de Paillerets B, Calista D, Carrera C, Hansson J, Harland M, Hogg D, Höiom V, Holland EA, Ingvar C, Landi MT, Lang JM, Mackie RM, Mann GJ, Ming ME, Njauw CJ, Olsson H, Palmer J, Pastorino L, Puig S, Randerson-Moor J, Stark M, Tsao H, Tucker MA, van der Velden P, Yang XR, Gruis N, Melanoma Genetics Consortium.
    J Natl Cancer Inst; 2010 Oct 20; 102(20):1568-83. PubMed ID: 20876876
    [Abstract] [Full Text] [Related]

  • 2. MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.
    Fargnoli MC, Gandini S, Peris K, Maisonneuve P, Raimondi S.
    Eur J Cancer; 2010 May 20; 46(8):1413-20. PubMed ID: 20189796
    [Abstract] [Full Text] [Related]

  • 3. Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries.
    Goldstein AM, Chaudru V, Ghiorzo P, Badenas C, Malvehy J, Pastorino L, Laud K, Hulley B, Avril MF, Puig-Butille JA, Miniere A, Marti R, Chompret A, Cuellar F, Kolm I, Mila M, Tucker MA, Demenais F, Bianchi-Scarra G, Puig S, de-Paillerets BB.
    Int J Cancer; 2007 Aug 15; 121(4):825-31. PubMed ID: 17397031
    [Abstract] [Full Text] [Related]

  • 4. Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees.
    Chaudru V, Laud K, Avril MF, Minière A, Chompret A, Bressac-de Paillerets B, Demenais F.
    Cancer Epidemiol Biomarkers Prev; 2005 Oct 15; 14(10):2384-90. PubMed ID: 16214921
    [Abstract] [Full Text] [Related]

  • 5. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
    Landi MT, Kanetsky PA, Tsang S, Gold B, Munroe D, Rebbeck T, Swoyer J, Ter-Minassian M, Hedayati M, Grossman L, Goldstein AM, Calista D, Pfeiffer RM.
    J Natl Cancer Inst; 2005 Jul 06; 97(13):998-1007. PubMed ID: 15998953
    [Abstract] [Full Text] [Related]

  • 6. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
    Duffy DL, Lee KJ, Jagirdar K, Pflugfelder A, Stark MS, McMeniman EK, Soyer HP, Sturm RA.
    Br J Dermatol; 2019 Nov 06; 181(5):1009-1016. PubMed ID: 30820946
    [Abstract] [Full Text] [Related]

  • 7. CDKN2A and MC1R variants influence dermoscopic and confocal features of benign melanocytic lesions in multiple melanoma patients.
    Bassoli S, Maurichi A, Rodolfo M, Casari A, Frigerio S, Pupelli G, Farnetani F, Pelosi G, Santinami M, Pellacani G.
    Exp Dermatol; 2013 Jun 06; 22(6):411-6. PubMed ID: 23711066
    [Abstract] [Full Text] [Related]

  • 8. MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients.
    Ghiorzo P, Bonelli L, Pastorino L, Bruno W, Barile M, Andreotti V, Nasti S, Battistuzzi L, Grosso M, Bianchi-Scarrà G, Queirolo P.
    Exp Dermatol; 2012 Sep 06; 21(9):718-20. PubMed ID: 22804906
    [Abstract] [Full Text] [Related]

  • 9. MC1R variants, melanoma and red hair color phenotype: a meta-analysis.
    Raimondi S, Sera F, Gandini S, Iodice S, Caini S, Maisonneuve P, Fargnoli MC.
    Int J Cancer; 2008 Jun 15; 122(12):2753-60. PubMed ID: 18366057
    [Abstract] [Full Text] [Related]

  • 10. Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families.
    Chaudru V, Chompret A, Bressac-de Paillerets B, Spatz A, Avril MF, Demenais F.
    J Natl Cancer Inst; 2004 May 19; 96(10):785-95. PubMed ID: 15150307
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families.
    Peric B, Cerkovnik P, Novakovic S, Zgajnar J, Besic N, Hocevar M.
    BMC Med Genet; 2008 Sep 19; 9():86. PubMed ID: 18803811
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations.
    Goldstein AM, Landi MT, Tsang S, Fraser MC, Munroe DJ, Tucker MA.
    Cancer Epidemiol Biomarkers Prev; 2005 Sep 19; 14(9):2208-12. PubMed ID: 16172233
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.